Phase I Trial of Prednisone, Abiraterone, Cabazitaxel and Enzalutamide (PACE) for Metastatic Castration-resistant Prostate Cancer (mCRPC)
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 22 Aug 2017
At a glance
- Drugs Abiraterone (Primary) ; Cabazitaxel (Primary) ; Enzalutamide (Primary) ; Prednisone (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions
- 15 Aug 2017 Planned initiation date changed from 1 Aug 2017 to 1 Nov 2017.
- 19 Jun 2017 Planned initiation date changed from 1 Jun 2017 to 1 Aug 2017.
- 17 Apr 2017 New trial record